Medical &Health

Brazil approves Pfizer Covid vaccine for widespread use

Brazil’s health regulatory agency said

Tuesday it had approved the Pfizer-BioNTech Covid-19 vaccine for widespread

use, as the country races to secure enough doses to contain one of the

world’s worst outbreaks.

“It gives me great pleasure to announce that after a 17-day review,

(regulators) have granted the first approval in the Americas for widespread

use of a vaccine against Covid-19,” said Antonio Barra Torres, the director

of federal health regulator Anvisa, underlining that the approval was

definitive and not only for emergency use.

However, the vaccine is not yet available in Brazil, which is so far using

two others: Chinese-developed CoronaVac and one developed by Oxford

University and British-Swedish pharmaceutical firm AstraZeneca.

Source: Bangladesh Sangbad Sangstha (BSS)